Cibus competitors

ennifer Good is the co-founder of Trevi Therapeutics and serves as a director as well as the Company's President and Chief Executive Officer. Prior to founding Trevi, Ms. Good successfully led the transition of a publicly traded life sciences company, Penwest Pharmaceuticals Co., from a development stage company to generating annual revenues in excess of $50 million with strong profitability. The Company was acquired by its strategic partner in 2010. Ms. Good received a Bachelor of Business Administration degree with a Concentration in Accounting from Pacific Lutheran University in 1987 and is a Certified Public Accountant licensed by the State of Washington, although her license is currently inactive. Ms. Good currently serves on the board of the Friedreich's Ataxia Research Alliance (FARA), which is a patient advocacy group advancing treatments for the cure of Friedreich's Ataxia. In 2007, Ms. Good received the Connecticut Technology Counsel's Small Business Innovation and Leadership Award, and was a nominee in 2014 for the Entrepreneurial Innovation and Leadership Award.